Despite the mutual dependence of β-CATENIN and TCF7L2 in healthy IECs and for tumor initiation, high proportions of colorectal cancer genomes carry inactivating mutations in the TCF7L2 gene5,13,14,33. This evidence concerns the gene TCF7L2 and colorectal cancer.